The purpose of this study is to implement a support interdisciplinary program(oncologists, pharmacists, physicians, nurses, leagues against cancer) of medication adherence to oral oncology treatments. The aim is to ensure continuity of care between professionals,effectiveness of treatment and patient safety.
80 patients will be included in swiss-romande hospitals and private oncologists and followed by thirty study pharmacies. Each refusal and drop-out will be documented. Follow-up duration is 48 weeks, with a motivational interviewing at least every three months. Patient adherence will be assessed electronically by MEMS (Medication Event Monitoring System).
Study Type
OBSERVATIONAL
Enrollment
43
Policlinique Médicale Universitaire and Centre pluridisciplinaire d'oncologie, CHUV
Lausanne, Canton of Vaud, Switzerland
Change in Medication adherence
MEMS data, completed by informations given in motivational interviewing
Time frame: 3 months, 6 months, 9 months, 12 months
Program implementation
Evaluating the implementation of the program in pharmacies
Time frame: 1 year
Oncologists, nurses, pharmacists and patients satisfaction
By questionnaire and interviews
Time frame: 1 year
Effect of Adverse Drug Reaction (ADR) on medication adherence
By MEMS data and motivational interviewing informations
Time frame: 1 year
Change in Adverse Drug Reaction (ADR)
To evaluate the frequency and severity of ADR and the pharmacist's contribution to their management. Data from motivational interviewing.
Time frame: 3 months, 6 months, 9 months, 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.